- Conditions
- Breast Cancer, Hot Flashes
- Interventions
- pregabalin, placebo
- Drug · Other
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 207 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2015
- U.S. locations
- 209
- States / cities
- Scottsdale, Arizona • Aurora, Colorado • Boulder, Colorado + 135 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 97
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Hot Flushes, Menopause, Postmenopause
- Interventions
- Esterified Estrogens (EE) and Methyltestosterone (MT)
- Drug
- Lead sponsor
- Solvay Pharmaceuticals
- Industry
- Eligibility
- 45 Years to 65 Years · Female only
- Enrollment
- 1,251 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 88
- States / cities
- Montgomery, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 69 more
- Conditions
- Breast Cancer, Fatigue, Hot Flashes, Sleep Disorders
- Interventions
- Paced breathing (15 min once daily, 6 breaths/min), Paced breathing (15 min twice daily, 6 breaths/min), Paced breathing (10 min once daily, 14 breaths/min)
- Behavioral
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 120 Years · Female only
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2012
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Hot Flashes
- Interventions
- Fezolinetant, placebo
- Drug
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Industry
- Eligibility
- 40 Years to 65 Years · Female only
- Enrollment
- 501 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 65
- States / cities
- Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 53 more
- Conditions
- Breast Cancer, Hot Flashes, Hot Flushes
- Interventions
- soy protein, isoflavones, Tamoxifen, Placebo
- Dietary Supplement · Drug · Other
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2013
- U.S. locations
- 14
- States / cities
- Rockford, Illinois • Elkhart, Indiana • Kokomo, Indiana + 9 more
- Conditions
- Hot Flashes
- Interventions
- Brisdelle (paroxetine mesylate), Sugar pill
- Drug
- Lead sponsor
- Noven Therapeutics
- Industry
- Eligibility
- 41 Years and older · Female only
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 10
- States / cities
- Lake Worth, Florida • Naples, Florida • Greensboro, North Carolina + 6 more
- Conditions
- Breast Cancer, Depression, Hot Flashes, Psychosocial Effects of Cancer and Its Treatment
- Interventions
- citalopram hydrobromide, escitalopram oxalate, gabapentin, sertraline hydrochloride, tamoxifen citrate, venlafaxine, molecular genetic technique, high performance liquid chromatography, laboratory biomarker analysis, pharmacological study, adjuvant therapy
- Drug · Genetic · Other + 1 more
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 6
- States / cities
- Indianapolis, Indiana • Baltimore, Maryland • Ann Arbor, Michigan + 3 more
- Conditions
- Postmenopausal Symptoms
- Interventions
- Brisdelle (paroxetine mesylate), Placebo capsules
- Drug
- Lead sponsor
- Noven Therapeutics
- Industry
- Eligibility
- 40 Years and older · Female only
- Enrollment
- 614 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 74
- States / cities
- Mobile, Alabama • Chandler, Arizona • Glendale, Arizona + 63 more
- Conditions
- Hot Flashes
- Interventions
- medroxyprogesterone, venlafaxine
- Drug
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 227 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2006
- U.S. locations
- 22
- States / cities
- Scottsdale, Arizona • Jacksonville, Florida • Honolulu, Hawaii + 19 more
- Conditions
- Hot Flashes, Menopause, Vasomotor Disturbance, Sleep
- Interventions
- Cognitive Behavioral Therapy-Insomnia (CBT-I), Menopause Education Control (MEC)
- Behavioral
- Lead sponsor
- Fred Hutchinson Cancer Center
- Other
- Eligibility
- 40 Years to 65 Years · Female only
- Enrollment
- 106 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Breast Cancer, Hot Flashes
- Interventions
- black cohosh, placebo
- Dietary Supplement · Other
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 132 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 13
- States / cities
- Scottsdale, Arizona • Jacksonville, Florida • Urbana, Illinois + 10 more
- Conditions
- Hot Flashes
- Interventions
- Gabapentin Extended-Release (G-ER) 1200 mg, Gabapentin Extended-Release (G-ER) 1800 mg, Placebo
- Drug
- Lead sponsor
- Depomed
- Industry
- Eligibility
- 18 Years to 70 Years · Female only
- Enrollment
- 565 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 45
- States / cities
- Birmingham, Alabama • Chandler, Arizona • Scottsdale, Arizona + 40 more
- Conditions
- Hot Flashes
- Interventions
- Fezolinetant, Paroxetine, Citalopram, Escitalopram, Desvenlafaxine, Venlafaxine, Gabapentin, Clonidine, Pregabalin, Oxybutynin, Any other SSRI/SNRI not already specified, Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above
- Drug
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Industry
- Eligibility
- 40 Years to 75 Years · Female only
- Enrollment
- 999 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 48
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Lomita, California + 39 more
- Conditions
- Hot Flashes, Prostate Cancer
- Interventions
- gabapentin, placebo
- Drug · Other
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 223 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2007
- U.S. locations
- 170
- States / cities
- Mobile, Alabama • Washington D.C., District of Columbia • Jacksonville, Florida + 103 more
- Conditions
- Hot Flashes
- Interventions
- Estradiol transdermal one 90 μL spray, Estradiol transdermal spray, two 90 μL sprays, Estradiol transdermal three 90 μL sprays, Placebo transdermal two 90 μL sprays, Placebo transdermal three 90 μL sprays, Placebo transdermal one 90 μL spray
- Drug
- Lead sponsor
- Lumara Health, Inc.
- Industry
- Eligibility
- 35 Years and older · Female only
- Enrollment
- 454 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 43
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Oro Valley, Arizona + 37 more
- Conditions
- Prostate Cancer, Hot Flashes
- Interventions
- Embr thermal device
- Device
- Lead sponsor
- Embr Labs, Inc.
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Vasomotor Symptoms Associated With Menopause, Hot Flashes
- Interventions
- Elinzanetant (BAY3427080), Placebo
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 40 Years to 65 Years · Female only
- Enrollment
- 628 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 36
- States / cities
- Mobile, Alabama • Mesa, Arizona • Garden Grove, California + 30 more
- Conditions
- Vasomotor Symptoms, Hot Flashes
- Interventions
- 0.5mg DRSP / 0.5mg E2 (BAY86-4891), 0.25mg DRSP / 0.5mg E2 (BAY86-4891), Estradiol (E2 0.3mg), Placebo
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 40 Years and older · Female only
- Enrollment
- 735 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 76
- States / cities
- Mobile, Alabama • Chandler, Arizona • Phoenix, Arizona + 64 more
- Conditions
- Menopause
- Interventions
- Paroxetine, placebo
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 40 Years and older · Female only
- Enrollment
- 64 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004 – 2006
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Hot Flashes, Menopause, Vasomotor Disturbance
- Interventions
- Low-dose 17-ß-estradiol with progesterone taper, Venlafaxine XR, Placebo
- Drug
- Lead sponsor
- Fred Hutchinson Cancer Center
- Other
- Eligibility
- 40 Years to 62 Years · Female only
- Enrollment
- 339 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2013
- U.S. locations
- 4
- States / cities
- Boston, Massachusetts • Chestnut Hill, Massachusetts • Philadelphia, Pennsylvania + 1 more
- Conditions
- Hot Flashes
- Interventions
- Gabapentin Extended Release tablets, Gabapentin
- Drug
- Lead sponsor
- Depomed
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 108 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 8
- States / cities
- Burbank, California • DeLand, Florida • Port Orange, Florida + 5 more
- Conditions
- Hot Flashes
- Interventions
- Black cohosh
- Drug
- Lead sponsor
- National Center for Complementary and Integrative Health (NCCIH)
- NIH
- Eligibility
- 18 Years to 70 Years · Female only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2003 – 2008
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Prostate CA, Androgen Deprivation Therapy
- Interventions
- Fezolinetant
- Drug
- Lead sponsor
- University of Vermont
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Burlington, Vermont
- Conditions
- Cancer
- Interventions
- caspofungin acetate, liposomal amphotericin B
- Drug
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 16 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2000
- U.S. locations
- 1
- States / cities
- New York, New York